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Introduction
vasa was identified in a genetic screening as one of the several maternal-effect genes for the embryonic polarity and germ cell formation in Drosophila (Hay et al., 1988) . The Drosophila Vasa protein is a component of polar granules of the oocyte and expressed specifically throughout germ cell development (Lasko and Ashburner, 1988) . vasa is an ATPdependent DEAD box RNA helicase, similar to the eukaryotic initiation factor 4A and acts as a translational regulator of two Drosophila mRNAs: one is gurken that directs the embryonic polarity, and the other is oskar that directs posterior germ 0925-4773/$ -see front matter Ó 2009 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2009.02.004 plasm assembly and can induce germ cell formation in ectopic sites (Ephrussi and Lehmann, 1992) . Both gurken and oskar are translationally repressed by the bruno gene product until they reach destinations in the oocyte leading to localized protein accumulation. vasa appears to function in relieving the repression of gurken and oskar mRNA by bruno (Johnstone and Lasko, 2004) . Mutations in the helicase domain of Vasa cause the lack of gurken and oskar translation, leading to germ cell defects and female sterility (Lasko and Ashburner, 1988) . The Drosophila vasa homolog has been identified in diverse species including the hydra (Mochizuki et al., 2001) , planarian (Shibata et al., 1999) , zebrafish (Yoon et al., 1997) , medaka (Shinomiya et al., 2000) , mouse (Fujiwara et al., 1994) and human (Castrillon et al., 2000) . vasa is highly conserved across animal phyla in protein sequence and intracellular localization, and exhibits a germline-specific expression.
The conserved structure and expression pattern suggest an essential role of vasa in germline development. So far, the function of vasa has been studied in several organisms.
In Drosophila, vasa mutations lead to the loss of primordial germ cell (PGC) formation (Hay et al., 1988) , excluding the possibility to observe the role of vasa in late stages of germline development. In Caenorhabditis elegans, antisense RNA-mediated knockdown of vasa homologs (glh1 to glh4) results in some sterile adults largely due to defects in late stages of germline development, namely gametogenesis (Gruidl et al., 1996; Kuznicki et al., 2000) . In Xenopus laevis, injection of an antibody against the Vasa protein into presumptive PGCs at the 32-cell stage remarkably reduced the number of PGCs at the tadpole stage (Ikenishi and Tanaka, 1997) . In mouse, targeted disruption of the vasa gene resulted in serious defects in male sterility, again due to defective germ cell proliferation and differentiation in the gonad . In zebrafish, a morpholino oligo can knockdown vasa translation but does not affect the establishment of the germline (Braat et al., 2001) . Therefore, the precise processes affected by vasa mutation and knockdown vary considerably in diverse organisms. The small laboratory fish medaka (Oryzias latipes) is an excellent model for analyzing vertebrate development (Wittbrodt et al., 2002) , embryonic stem cells (Hong et al., , 1998a (Hong et al., , 2004b and germ cell biology (Hong et al., 2004a) . Specifically, medaka is well suited for analyzing germline development throughout embryogenesis and adult life. Medaka PGCs can easily be traced by transgenic GFP expression or zygotic injection of germ plasm-localized GFP (Kurokawa et al., 2006) . Gene knockdown by using morpholino oligos (Nasevicius and Ekker, 2000) has proven a powerful tool in both zebrafish and medaka for analyzing PGC development. For example, knockdown of zebrafish genes nanos (Kö prunner et al., 2001) or dnd (Weidinger et al., 2003) leads to clear defects in PGC migration and/or survival.
Medaka exhibits several unique features in early germline development. vasa is maternally inherited in this organism, similar to the situation in zebrafish. However, medaka vasa widely distributes until early gastrulation, in sharp contrast to asymmetric segregation to few presumptive PGCs as seen in Drosophila and zebrafish that inherit maternal germ plasm for cell-autonomous PGC specification (Knaut et al., 2000; Raz, 2003) . Medaka also exhibits distinct features in PGC migration (Shinomiya et al., 2000; Kurokawa et al., 2006) . By using morpholino gene knockdown, cell tracing, cell culture, marker staining and chimera formation, we have revealed the specific role of medaka vasa in PGC migration.
Results

Experimental fish model system
To investigate the function of vasa in medaka PGC development we obtained three transgenic lines that express GFP or RFP exclusively by the medaka vasa (V) or nanos (N) promoter. Transgenic lines Vg and Vr contain the transgene olVas-gfp ) and olVas-rfp (unpublished), respectively. Ng contains the transgene olNos-gfp (unpublished). We employed transgenic embryos to trace PGCs in a transparent environment. The Vg transgene products (RNA and protein) are maternally supplied and widely distributed until gastrulation . To avoid this maternal background, we took the advantage that zygotic transcription in medaka does not occur before the midblastula stage (Aizawa et al., 2003) . To this, hybrid Vg embryos were produced by mating wild-type females to transgenic Vg males for PGC visualization. Zygotic expression of a sperm-derived transgene allows for unambiguous identification of PGCs by background-free GFP signal from stage 22 onwards (see below). To trace PGCs at earlier stages, we used homozygous Ng embryos or double transgenic NgVg embryos, the latter was produced by mating Ng females to Vg males. A combination of these transgenic lines provides a powerful tool to trace PGCs at different stages of embryonic development.
Early phenotypes by vasa knockdown
To investigate the function of vasa in medaka PGC development we designed two morpholino-modified antisense oligonucleotides (shortly morpholino afterwards) to inhibit its translation in early embryos by microinjection. The first morpholino MOvas targets the translational start site of the vasa mRNA. Zygotic injection of MOvas produced three classes of phenotypes (morphants) ( Table 1 ). Compared to the control (Fig. 1A- 
vasa is required for migration of medaka PGCs
The most apparent phenotype upon vasa knockdown by MOvas-injection was found on PGC development. By stage 22, PGCs are clearly visible and readily countable by transgenic GFP expression. At this stage, a control embryo has 32.3 PGCs on average (Fig. 1R) , whereas an average of 25.6 and 22.3 PGCs was observed in embryos injected with 1.5 and 3 ng of MOvas (Fig. 1R) , respectively. These results suggest that vasa knockdown under these conditions has little effect on the PGC number in medaka. The ability to establish a substantial number of PGCs in vasa-depleted embryos enabled us to follow their behaviors in subsequent stages of development. Remarkably, embryos injected with MOvas exhibited severe defects in PGC migration, as evidenced by abnormal distributions (Fig. 1) . Medaka PGC migration proceeds in four major steps: (1) convergence to the embryonic shield until mid gastrulation, (2) convergence to the embryonic axis until late gastrulation, (3) bilateral alignment along the axis and (4) posterior migration into dense bilateral clusters in the ventral lateral areas of the abdomen (Shinomiya et al., 2000; Kurokawa et al., 2006) . To determine precisely which steps were affected by vasa knockdown, we focused on class I mild morphants, where major embryonic structures are largely normal ( Fig. 1E-F) , and PGC positions relative to embryonic compartments are easily identifiable (Fig. 1E 0 -F 0 ). In these embryos, PGCs were able to migrate properly to the bilateral positions to initiate alignment into two rows dorsal to the embryonic axis at stage 19, comparable to the normal medaka PGC migration in the control (data not shown). These PGCs initiated but failed to complete the alignment into two compacted clusters, resulting in two broadly aligned groups by stage 22 ( by stage 27. These observations suggest that the PGC migration defect by vasa knockdown commences from the end of step 2 and persists in steps 3 and 4. When injected at 1.5 ng, MOvas produced up to 82.3% (36 out 43) of class I embryos with ectopic PGCs (Fig. 1S) , and the average number of ectopic PGCs was 10.7 (Fig. 1T ). The PGC migration defect is more severe in class II and III morphants. In class II, the majority of PGCs were ectopic, with few PGCs being found ultimately in the gonad ( Fig. 1H-I 0 ). In class III, PGCs appeared to randomly distribute over the entire, disorganized embryo lacking an apparent gonad ( Fig. 1J -L 0 ). A higher dose at 3 ng significantly increased the number of abnormally developing embryos ( Fig. 1J ) and embryonic lethality (data not shown). All embryos (n = 34) following injection with 3 ng of MOvas possessed ectopic PGCs (Fig. 1S ). Our subsequent analyses will focus on class I embryos following MOvas injection at 1.5 ng unless otherwise indicated.
Specificity of vasa knockdown phenotype
The specificity of vasa knockdown by MOvas was indicated by six experiments. First, the control morpholino MOvc with six mismatches resulted in wild-type embryos ( Fig. 1A-C) . Second, irrelevant morpholinos targeting other mRNAs produced different phenotypes (data not shown). To analyze vasa morphants in more detail, the third experiment generated mosaic embryos in which one side serviced as the control and the other vasa morphant, by injecting 0.75 ng of MOvas into one cell of the 2-cell embryos (equivalent to 1.5 ng/embryo for zygotic injection). Unlike the zebrafish embryo, the medaka embryo has a yolk membrane between the cell mass and yolk material and thus allows for injection into only one cell of the 2-cell embryo. All of 18 carefully injected embryos exhibited wild-type development and somitogenesis ( Fig. 2A) , and normally hatched (data not shown). Earlier in these embryos at stage 22, the half from the injected cells had a few PGCs that displayed a small yet detectable distance from the central region of bilateral alignment ( Fig. 2B and C, arrows); at 5 dpf, one side was essentially free of ectopic PGCs, whereas the other had many ectopic PGCs ( Fig. 2D and E ). The precise comparison of PGC distribution between normal and MOvas-injected sides conforms to our observation in embryos following zygotic MOvas injection. In addition, normal somatic development in both sides of mosaic embryos and the presence of numerous ectopic PGCs in one side only argue against the non-specific effect of the morpholino and the somatic environment on the PGC morphant observed.
Direct evidence for the specificity of vasa morphants came from phenotype-rescuing experiments. To this, the medaka vasa cDNA sequence was modified by introducing six mismatches so that its mRNA can no longer be targeted by MOvas. Co-injection of this vasa RNA reduced the abnormal embryos, producing more class I and less class II and III embryos (Table 1 and Fig. 1Q ). More importantly, vasa RNA was able to rescue the PGC morphant to some extent ( Fig. 2F -J). Specifically, in these co-injected embryos, there were rare ectopic PGCs until PGCs started directional migration toward the gonad (Fig. 2H) . However, at stage 27 when PGCs reach the gonad of control embryos (Fig. 1C 0 ), many PGCs in the co-injected embryos were not in to the gonad but appeared ectopically to its close proximity ( Fig. 2I and J) , indicating that the defect in the last step of PGC migration to enter the gonad is insufficiently rescued by vasa RNA injection. Since injection of a morpholino in fish often results in activation of p53, leading to off-target effect (Robu et al., 2007) , the fifth experiment aimed to rule out this possible off-target effect. When MOvas was co-injected with MOp53, a morpholino against the medaka p53 mRNA, the same PGC phenotype was observed (Fig. 3A-C) . Finally, the second morpholino MOvas2 produced the same PGC phenotype ( Fig. 3D and E) as by MOvas and was indeed able to reduce the GFP signal in Vg (Fig. 3D) but not in Ng embryo (Fig. 3E) , and this reduction in GFP signal appeared to be the consequence of translation suppression but not of PGC loss, as the GFP signal and the PGC number were not affected by MOvas2 in the Ng background (Fig. 3E) . The target sequence of MOvas2 is upstream of the MOvas target ( Fig. 3F and G) , which is present also in the chimeric Vg mRNA. This suggests that the PGC migration defect caused by MOvas and MOvas2 may be the direct consequence of vasa depletion.
2.5.
vasa is dispensable for the medaka PGC identity, survival and motility in vivo
The migratory defect upon vasa knockdown raised a question as to whether the ectopic cells identified as PGCs by morphology and transgenic olVas-GFP expression were indeed PGCs. To address this, we determined three additional critical features of PGCs. We found that the GFP-positive cells in MOvas-injected Vg embryos -regardless of proper or ectopic locations, expressed dazl RNA (Fig. 2K and L (M and N) Embryos by stage 34. Similar stability and localized perinuclear speckles of the Nanos:GFP fusion protein (green) from injected nos:fgp RNA are seen in both MOvc-and MOvas-injected embryos. Notably, the GFP intensity and nuclear speckle formation are normal also in ectopic PGCs of MOvas-injected embryos (asterisks in N).
have proven to be essential for PGC migration and survival. We wanted to determine whether vasa knockdown would also affect PGC identity and/or survival. To this end, we made serial observations on PGC numbers at various stages in vasa-depleted class II embryos due to numerous ectopic PGCs that were precisely countable and easily traceable by relative locations. We were unable to detect the loss of ectopic PGCs in all of the five embryos examined at 3, 5, 7 and 9 dpf ( Fig. 4A-D) , and none of individual ectopic PGCs disappeared. PGCs at ectopic sites even increased in number and changed their positions ( Fig. 4B and C) . Taken together, vasa-depleted PGCs undergo neither a fate transition to somatic cells (as evidenced by PGC-specific GFP expression) nor cell death, and are capable of continuous proliferation and movements even in ectopic locations in vivo.
The above observation in living embryos was made on ectopic PGCs. In order to extend our analysis to all PGCs, we established a cell culture system to analyze the PGC behaviors at the single cell level. Individual cells were dissociated from control and vasa-depleted NgVg embryos at early gastrulation and cultured in 96-well plates for continuous inspection. In this culture system, both MOvc-and MOvas-injected gastrula cells underwent rapid cell division and formed cell aggregates until 2 h post culture (hpc; Fig. 5A and B) , attached to gelatincoated substrata at 4 hpc ( Fig. 5C and D) , began to produce cells with increased GFP at 6 hpc (data not shown) and eventually generated readily countable PGCs on a monolayer of somatic cells until 2 days post culture (dpc) (Fig. 5E and F) . A control embryo in culture (n = 25) gave rise to 25.5 PGCs on average (Fig. 5I) . This amounts to an 80% recovery rate compared with 32.3 obtained in living embryos (Fig. 1B 0 and R), indicating that this cell culture system is efficient for analyzing PGC behaviors in vitro at the single cell level. We observed 25.2 PGCs for vasa-depleted embryos (n = 14) (Fig. 5I) . By serial observations until 8 dpc, we failed to detect any significant difference in time course changes of PGC number between MOvas-and MOvc-injected embryos (Fig. 5I) . Therefore, we speculate that vasa-depletion does not affect PGC proliferation and survival in vitro. We observed that vasa-depleted PGCs and somatic cells did not differ from their control counterparts in motility, as they steadily formed filopodia and changed their relative positions by ameba-like locomotion at 1 dpc (Fig. 5G) . This motility disappeared immediately afterwards in ES-like cells and somatic cells but persisted in PGCs up to 3 dpc (Fig. 5H) and even throughout the entire period of culture (9 days; data G AGGCCGCGAGGACAAGAAAAGTTCTTAAATAGTTGATCAGACGATTAAAATGGACGACTGGGAGGAAGAGGA
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2.6.
vasa is cell-autonomously required for migration of medaka PGCs PGC migration depends on both the intrinsic ability of PGCs for directional locomotion and the somatic environment comprising the migratory route. To determine whether vasa was directly or indirectly required for medaka PGC migration, we first compared control and MOvas-injected embryos in the spatial expression patterns at the critical stages of wt1 and sdf1, the genes that have been analyzed in detail for expression in somatic tissues of the migration pathway including the lateral plate mesoderm (LPM), through which PGCs migrate (Kurokawa et al., 2006; Herpin et al., 2008; Klü ver et al., 2009) . As illustrated in Fig. 6 , neither the expression levels nor expression territories of both genes was altered by vasa knockdown. This suggests that the somatic environment in MOvas-injected embryos is largely normal, and that PGC migration defects by vasa gene knockdown is not a secondary effect. We also examined the expression pattern of cxcr4b that encodes the receptor of sdf1. It has been reported that cxcr4b is expressed in both PGCs and lateral line placodes, and is essential for PGC migration in zebrafish (Doitsidou et al., 2002; Knaut et al., 2003) and medaka (Kurokawa et al., 2006; Sasado et al., 2008) . The cxcr4b expression pattern was unchanged by MOvas-injection (Fig. 6 ), indicating that vasa knockdown does not affect the cxcr4b signaling.
Direct evidence for the cell-autonomous effect of vasa knockdown on PGC migration came from chimeric assays. Previously, we have shown that chimera formation is a powerful tool to analyze the cell fate and behavior (Hong et al., 1998a,b) . If vasa was cell-autonomously required for PGC migration, donor PGCs derived from MOvas-injected blastulae could migrate improperly in a normal host. To address this issue, we performed five series of chimera assays (Fig. 7A) by transplanting 20-50 genetically labeled blastomeres to a blastula host (Fig. 7B) , and examined donor PGC distribution by fluorescent microscopy ( Fig. 7C-J) . The first series serviced the control, where transplantation was between normal donor and host blastulae. A total of 108 donor PGCs were analyzed. Surprisingly, 31% (n = 33) distributed ectopically, and 69% (n = 75) was found in the migration route and/or gonad ( Fig. 7C and K) . For chimera formation, donor cells were randomly injected among deep cells. It is likely that only those donor-derived PGCs that were in the proper position at cell injection were able to properly migrate. This notion is supported by the fact that approximately 1% of endogenous PGCs are also ectopic even in MOvc-injected embryos (Table 1 ). In the second series, blastula cells from MOvas-injected embryos were transplanted. Out of 54 donor PGCs examined, up to 96% (n = 52) distributed in ectopic sites ( Fig. 7D and K) . In the third series, cells from vasa-depleted blastulae were cotransplanted together with control blastula cells. Out of 23 vasa-depleted donor PGCs (GFP-positive), the overwhelming majority (91%, n = 20) were again ectopic, whereas only 35% (8 out of 25) of control blastula-derived PGCs (RFP-positive) appeared ectopically ( Fig. 7E and K The fourth series aimed to examine whether a vasa-depleted somatic environment also contributed to the PGC migration defect. To this, blastulae derived from zygotic MOvas injection were used as the host for reciprocal transplantation of control blastomeres. In this experiment, embryos following zygotic injection became intolerant to the enzymatic dechorionation, a step necessary for cell transplantation in medaka (Hong et al., 1998a (Hong et al., ,2004b . Here embryos were first treated with proteinase K to remove the outer layer of the chorion and then with a crude medaka hatching enzyme preparation to remove the inner layer. Injection of a morpholino produced on the chorion a hole through which proteinase K could enter and digest the cell mass, resulting in embryo death. Of more than 400 operated embryos, we obtained eight chimeras with a total of 18 donor PGCs. Among them, 12 (67%) distributed properly, and only 6 (33%) were ectopic ( Fig. 7F and K) . Therefore, the vasa-depleted environment appears to have little effect on medaka PGC migration.
Chimera assays described so far have used non-transgenic hosts. The fifth series aimed to observe more precisely the distribution pattern of donor PGCs relative to their endogenous counterparts, we transplanted MOvas-injected Vg blastula cells into control Vr blastula hosts. In the resulting 7-dpf chimeras, endogenous PGCs (RFP-positive) were normally found in the gonad, whereas the vasa-ablated donor PGCs (GFP-positive) were again ectopically located outside (Fig. 7G-K) , consistent with the observations on PGC distribution in the non-transgenic host. Fig. 6 -Analyses of RNA expression profiles of wt1a, sdf1b and cxcr4b by whole mount in situ hybridization. Normal expression of wt1a, sdf1b and cxcr4b is seen in MOvas-injected embryos compared to MOvc-injected control embryos. By stage 22, wt1a is expressed in lateral plate mesoderm (lpm), sdf1b is high in the lpm and presomitic mesoderm (psm) and weak in the telencaphalon (tp), whereas cxcr4b is abundant in posterior lateral line placodes (pllp), olfactory placodes (op) and weak in the lateral somatic area where PGCs normally reside (dot line). By stage 34, similar expression patterns of the three genes are also seen in MOvas-and MOvc-injected embryos. gd, gonad; mn and pn, meso-and pronephros. Shown are representatives of 50 embryos in each experiment. Table 2. 3.
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Discussion
Germline development proceeds in distinct steps including germ cell specification, migration, proliferation, survival and differentiation. Abnormalities in any of these aspects will lead to defects in germline development and adult sterility. Studies reported so far in various organisms by different approaches point to a highly conserved role for vasa in the germline, considerable differences do, however, exist in terms of particular processes of germline development, ranging from the first step of PGC formation in Drosophila (Hay et al., 1988) to late stages of germ cell proliferation and differentiation in gametogenesis leading to adult sterility in C. elegans (Gruidl et al., 1996; Kuznicki et al., 2000) and mouse . The present study has demonstrated an essential role for vasa in medaka PGC migration.
3.1.
vasa is cell-autonomously required for medaka PGC migration at late stages
We have provided four lines of evidence that the specific role of the medaka vasa in early PGC development resides in the cell-autonomous requirement for late PGC migration. First, in class I of mild vasa morphant where embryonic development is largely normal, PGCs can properly develop and migrate to the bilateral positions to initiate alignment into two rows dorsal to the embryonic axis at stage 19 essentially as described for normal medaka PGC migration (Shinomiya et al., 2000; Kurokawa et al., 2006; Herpin et al., 2008) . These PGCs can distribute bilaterally and initiate but, however, cannot complete the alignment into two clusters at stage 22. Medaka PGCs until bilateral alignment do not show active movement (Kurokawa et al., 2006; Herpin et al., 2008) . Our observation extends these reports by indicating that the alignment proceeds in two sub-steps: bilateral distribution and alignment, the latter requiring vasa function. By the end of stage 22 when aligned PGCs in the normal embryo commence migration towards the developing gonad, vasa-depletion leads to a wider range of PGC distribution. Consequently, numerous PGCs are found outside the migratory route and do not enter the gonad at stage 27. Therefore, the PGC migration defect by vasa knockdown commences late at the alignment step. Second, vasa depletion does not affect the proliferation, survival and motility of migratory and post-migratory PGCs, as these PGCs do not disappear but continue cell divisions and change their relative locations, even at ectopic sites of living embryos. Third, we have -by cell culture analysesdemonstrated that control and vasa-depleted gastrulae produced the same number of initial PGCs and exhibited the same time course for PGC growth and/or survival. More importantly, vasa depletion does not compromise the motility of PGCs, as they are able to form filopodia, change cell shapes and undergo ameba-like locomotion in culture.
Finally, we have analyzed the cellular basis for the migration defect in vasa-depleted PGCs by marker gene expression and chimera formation. On one hand, we show that somatic tissues of the PGC migratory route appears normal as evidenced by the expression patterns of three marker genes, namely, wt1a, sdf1b and cxcr4b, which have been reported to be essential for medaka PGC migration (Kurokawa et al., 2006; Herpin et al., 2008; Sasado et al., 2008; Klü ver et al., 2009) . This argues against a secondary effect on PGC migration due to an altered somatic environment. On the other hand, chimera formation has provided direct evidence for the cell-autonomous requirement of vasa in PGC migration. Strikingly, donor PGCs derived from vasaablated blastulae do not properly migrate in the normal host environment (i.e. migratory route) to enter the gonad but show the same defect, namely, ectopic location from stage 22 onwards; whereas donor PGCs from normal blastulae often distribute properly in the vasa-ablated environment. This leads us to speculate that vasa functions cell-autonomously, and that vasa depletion would result in the loss of PGCs 0 responsiveness to the directional signal for migration towards the gonad. Recently, several genes have been shown to be essential for fish PGC migration. These include the zebrafish nanos (Kö prunner et al., 2001) , dnd (Weidinger et al., 2003 ), cxcr4b (Doitsidou et al., 2002 Knaut et al., 2003) , the medaka sdf1 (Kurokawa et al., 2006; Herpin et al., 2008) , cxcr4b and cxcr7 (Kurokawa et al., 2006; Sasado et al., 2008) . In this regard, our medaka vasa morphant differs from the zebrafish nanos and dnd morphants, in that the knockdown of medaka vasa does not affect PGC survival, motility and early migration. There is also a clear difference between the vasa and cxcr7 morphants: PGCs in cxcr7 homozygous mutant embryo until stage 17 are widely scattered throughout the embryo, rather than being posteriorly confined, some even locating away from the embryonic body (Sasado et al., 2008) , while this step appears normal in the vasa morphant. Interestingly, the vasa morphant is similar to the cxcr4b mutant phenotype. In the cxcr4b homozygous mutant embryo, distribution of PGCs is indistinguishable from wild type at until stage 17 and PGCs line up bilaterally close to normal at stage 22, but then fail to make a posterior drift and remain as loosely aligned bilateral rows of cells distributed more anterior to the normal position of the PGC clusters (Sasado et al., 2008) . Our observation that both sdf1b and cxcr4b expression is normal in vasa-morphants implies that vasa knockdown does not affect the sdf-cxcr4 signaling in PGC migration. Braat et al. (2001) have reported that a zebrafish vasa morphant abolishes Vasa protein but does not affect the establishment of the germline by injecting a vasa morpholino. In the present study, we also failed to obtain a detectable phenotype by using a low dose of the first morpholino in medaka, whereas the second morpholino at the same dose reproducibly generated the PGC morphant. Furthermore, even in those embryos harboring many PGCs at ectopic sites, we usually observe the presence of a few PGCs in the gonad, and these medaka embryos can develop normal fertility (data not shown). Thus, the vasa morphant heavily depends on the dose and target sequence of morpholinos as well as the stage and penetrance of phenotypic observation.
In Drosophila, the primary phenotype of vasa mutations consists in the first step of germline development, namely loss of PGC formation due to the failure in germ plasm assembly (Lasko and Ashburner, 1988) . This excludes the possibility to observe any role of vasa in late stages of PGC development including PGC migration and survival. Our observations in vivo and in vitro suggest that vasa knockdown does not reduce the PGC number. Gene knockdown by a morpholino can only prevent zygotic translation after injection. Future work is needed to determine whether the amount of Vasa protein from maternal inheritance as well as from zygotic synthesis prior to morpholino knockdown is sufficient for early medaka PGC development.
3.2.
Medaka PGC identity is cell-autonomously maintained independently of vasa Adult male germ stem cells from the mouse testis have pluripotency capable of somatic differentiation (Guan et al., 2006) . However, the possibility for PGCs to undergo germline-soma fate transition in developing embryos has been controversial. In the mouse, premigratory PGCs and their cultures (embryonic germ cells; Matsui et al., 1992) can produce somatic cells, while migratory and post-migratory PGCs lost this potential and continue the germline program, as both male and female PGCs in ectopic sites autonomously enter meiosis (Francavilla and Zamboni 1985) . In Xenopus, migratory and post-migratory PGCs can differentiate into somatic cells (Wylie, 1999) . Knaut et al. (2000) reported that in zebrafish, both premigratory and migrating PGCs retain the germ fate even in ectopic embryonic compartments. In this study, we have presented direct evidence that the medaka PGCs do maintain the cell identity and other aspects (except proper migration) even in various somatic environments of living embryos and in culture. For example, ectopic PGCs in vasa morphants normally express the endogenous germ cell marker dazl RNA (Xu et al., 2007) , retain the ability to stabilize microinjected Nos3-localized nos:gfp RNA and more importantly, localize its protein product Nos:GFP fusion properly to form perinuclear speckles. These underscore that in medaka, the PGC identity is rigidly maintained by a cell autonomous and vasa-independent mechanism.
Five independent experiments suggest that the morpholino phenotype in PGC migration is ascribed to specific vasa gene knockdown. First, a similar but mutant vasa morpholino has no effect. Second, injection of a morpholino against the medaka p53 alone or together with a vasa morpholino does not produce the phenotype, ruling out the off-target effect by morpholino-induced p53 activation (Robu et al., 2007; Eisen and Smith, 2008) . Third, two independent vasa morpholino oligos targeting different regions of the vasa mRNA did produce the same PGC phenotype. Fourth, one morpholino that targets the vasa 5 0 untranslated region present also in the transgenic olvas-gfp mRNA can remarkably reduce the GFP signal in Vg transgenic embryos, indicating its efficiency in preventing an endogenous mRNA containing its target sequence from translation. Finally, vasa RNA is capable of phenotypic rescue. It deserves to note that injection of vasa RNA is unable to fully rescue the PGC morphant, possibly due to differential stability of the co-injected morpholino and vasa RNA. Our observation that many PGCs in co-injected embryos are properly positioned even after the bilateral alignment step and can reach the close vicinity to the gonad appears to be in support of this notion.
Experimental procedures
Fish and transgenic lines
Medaka was maintained at 26°C as described . Embryogenesis was staged according to Iwamatsu (2004) . Strain i 3 albino, see-through medaka (Wakamatsu et al., 2001 ) and three transgenic lines (Ng, Vg and Vr) were used to trace PGCs. Ng expresses GFP from the medaka nanos promoter, and Vg and Vr express GFP and RFP from the medaka vasa promoter. Founder fish of Vg were kindly provided by Professor Wakamatsu (Nagoya, Japan). This transgenic line was produced by introduction of olVas-gfp transgene (vasa promoter-GFP) into the see-through medaka (Wakamatsu et al., 2001) , which expresses GFP exclusively in germ cells . The Vg signal is maternally deposited and PGCs become clearly identifiable first until 3 days postfertilization (dpf). Both Ng and Vr were established in strain Hr-dR of medaka (unpublished data) and kindly provided to us by Professor Nagahama (Okazaki, Japan). Briefly, Ng was generated by introduction of medaka nanos promoter-gfp transgene and expresses GFP exclusively in early PGCs and female gonadal germ cells. Similarly, Vr was produced by introduction of olVas-rfp transgene and label germ cells at all stages. Ng allows for clear identification of early PGCs until 3 dpf, whereas Vg and Vr similarly identify PGCs from 3 dpf onwards (data not shown). For morpholino injection, embryos from mating between transgenic male (Vg or Vr) and nontransgenic female were used. Double transgenic embryos (NgVg) were generated by crossing transgenic Vg males to Ng females and used for cell cultures and/or morpholino injection. These NgVg embryos combine the zygotic translation of Ng transgene-derived maternal message and the zygotic expression of sperm-supplied Vg transgene. Consequently, this combination considerably enhances the signal to background ratio and facilitates unambiguous visualization of developing PGCs from as early as from 1 dpf onwards.
Constructs
Primers used are listed in Table S1 . The cDNAs for cxcr4b, sdf1b and wt1a were PCR-cloned into pGEM-T, resulting pTcxcr4b, pT-sdf1b and pT-wt1a (Fig. S1) , respectively. For preparation of capped RNAs, to produce pCSvachDZ, which expresses vasa in fusion to cherry-His tag linked to the medaka dazl 3 0 -UTR (DZ), the medaka vasa CDS was PCR-generated by using primers V1 (aaaggatccATGGAtGAtTGGGAaGAAGAGG; underlining depicts mismatches to the vasa morpholino, see below) and V2 (aaagaattcCTCCCAGTCATCTTCATC) and fused in frame to cherry:his by inserting between BamHI and EcoRI in pCS2, resulting in pCSvachSV that uses the SV40 3 0 -UTR.
Finally, pCSvachDZ was generated by replacing the SV40 3 0 -UTR with the 1-kb medaka DZ between XhoI and KpnI. The vasa sequence in the fusion harbors ten introduced mismatches spanning the ATG codon, which do not change the amino acid sequence but possibly abolish potential interference by MOvas (see below). Similarly, pCS2nos:gfNos3 0 UTR was constructed in three steps by linking the medaka nanos3:gfp coding sequence (CDS) to the nanos 3 0 UTR (Nos3). The Nos3 has been shown to be capable of specifically localizing and translating the fused RNA in PGCs (Kö prunner et al., 2001; Kurokawa et al., 2006) . The nanos CDS was PCR-cloned between BamHI and ClaI in pCS2. The gfp was PCR-cloned between ClaI and XhoI downstream of the Nanos. Finally, the Nos3 was PCR-amplified and inserted between XhoI and KpnI downstream of the nos:gfp fusion.
4.3.
RNA synthesis and whole mount in situ hybridization
Capped mRNA was synthesized from linearized pCSnos:gfpNos3 and pCSvachDZ by using the mMessage Machine kit (Ambion, Austin) and stored at À80°C until use. Synthesis of sense and antisense RNA probes from linearized plasmids by using the RNA labeling kit (Roche) and in situ hybridization were done essentially as described (Xu et al., 2007) .
Morpholino oligos
Antisense morpholino oligos (Gene Tool, Oregon) were dissolved in water at 10 mg/ml as stock. Four morpholinos were used in this study. MOvas (TTCCTCCCAGTCGTCCATTTTATC) and MOvas2 (TTTAAGAACTTTTCTTGTCCTCGCG) are against the medaka vasa mRNA sequence around the initiation codon (underlined; MOvas) and 20 nucleotides upstream the ATG (MOvas2) (Fig. 3F and G) . The sequences of both vasa morpholino oligos are present just once in the medaka genome, namely, gene vasa or ddx4 in Ultracontig 26 (http://www.ensembl.org/ Oryzias_latipes/contigview?gene=ENSORLG00000020672). MOvc (TTCtTCCCAaTCaTCCATaaaAATC) is a derivative of MOvas by introducing six mismatches (small case letter). MOp53 (GATCCATGCTTTCCCAACTTTGATG) is against the medaka p53 mRNA (NM_001104742) around the initiation codon (underlined). They were diluted to 0.5-5 ng/nl before use.
Microinjection
Medaka embryos were injected at the 1-or 2-cell stage (Hong et al., 2004a) . Briefly, the 1-cell and 2-cell embryo received 1 and 0.5 nl volume per injection, respectively. Successful injection and relative doses were monitored and sorted under a stereo microscope according to the intensity and distribution of the co-injected fluorescent dye Texas red (molecular weight 70,000; Molecular Probe, LA). Morpholinos (0.2-5 ng/nl) and the capped mRNA (0.1-0.3 ng/nl) were injected alone or in combination.
4.6.
Cell culture
Control and MOvas-injected embryos at stage 13 of the early gastrulation stage were used to initiate cell culture. At this stage, PGCs are first visible by a faint GFP signal in Ng-embryos (this study) or by localized expression of injected GFP mRNA fused to the nanos3 3 0 -UTR (Kurokawa et al., 2006) .
Individual embryos were dissociated mechanically and cultured on gelatin-coated 96-well plates in the medaka embryonic stem cell culture medium ESM2 .
Cell transplantation
Cell transplantation into midblastula recipients was performed essentially as described (Hong et al., 1998b ) with minor modifications. Briefly, cells within donor midblastulae were directly loaded into a microinjection needle by aspiration, and 20-50 cells were reintroduced among the deep cells of blastula hosts following dechorionation sequentially with proteinase K and hatching enzyme preparation (Hong et al., 1998a,b) . Genetically labeled PGCs of donor and host origin were derived from Vg, Vr and NgVg transgenic blastulae and traced by fluorescent microscopy. To analyze the effect of vasa-ablation on PGCs and somatic environment, MOvas was zygotically injected at 1.5 ng per donor and host embryos.
Microscopy
Whole embryos were visualized on a Leica MZFIII stereo microscope and photographed using a Nikon E4500 digital camera (Nikon Corp), observations and documentation of embryos at higher magnifications and cell cultures were under a Zeiss Axiovert invert microscope by using a Zeiss AxioCam MRc digital camera (Xu et al., 2005) .
Statistics
Statistical analyses were calculated by using Graphad Prism v4.0. Data consolidated were presented as means ± SEM and p values were calculated by using non-parametric student's t-test.
